• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺钼靶筛查时原位导管癌的检测有助于诊断小型3级浸润性肿瘤。

The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours.

作者信息

Evans A J, Pinder S E, Snead D R, Wilson A R, Ellis I O, Elston C W

机构信息

Department of Radiology, Nottingham City Hospital, UK.

出版信息

Br J Cancer. 1997;75(4):542-4. doi: 10.1038/bjc.1997.94.

DOI:10.1038/bjc.1997.94
PMID:9052407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2063314/
Abstract

This study was carried out to assess the frequency of ductal carcinoma in situ (DCIS) occurring within and surrounding grade 3 invasive tumours and the effect of its detection on size and nodal stage of invasive carcinomas at mammographic detection. Grade 3 tumours with either no associated DCIS or DCIS only within the invasive component were significantly larger in size than tumours with surrounding DCIS (P < 0.02) and were less likely to be under or equal to 10 mm in size (0% or 13% vs 30% respectively, P < 0.02). Tumours with mammographic calcification were more likely to be less than or equal to 10 mm in size than non-calcific tumours (32% vs 11% respectively, P < 0.05). This was because of the high frequency of tumours less than or equal to 10 mm in size in the linear/branching calcification group. Tumours showing calcification without a mass also appear to be a group with good prognostic features, with a mean size of 13 mm, 33% being 10 mm or less in size and only 17% being node positive. We have found that the presence of surrounding DCIS enables earlier detection of grade 3 invasive carcinomas because of the presence of mammographically visible calcification. Detection of calcification suggestive of DCIS should remain an important part of mammographic screening.

摘要

本研究旨在评估3级浸润性肿瘤内部及周围原位导管癌(DCIS)的发生频率,以及其检测对乳腺钼靶检查时浸润性癌的大小和淋巴结分期的影响。无相关DCIS或仅在浸润成分内有DCIS的3级肿瘤,其大小显著大于有周围DCIS的肿瘤(P < 0.02),且大小小于或等于10 mm的可能性较小(分别为0%或13%对30%,P < 0.02)。乳腺钼靶有钙化的肿瘤比无钙化的肿瘤更可能小于或等于10 mm(分别为32%对11%,P < 0.05)。这是因为线性/分支状钙化组中大小小于或等于10 mm的肿瘤频率较高。无肿块的钙化肿瘤似乎也是一组预后良好的特征,平均大小为13 mm,33%大小为10 mm或更小,仅17%有淋巴结转移。我们发现,由于乳腺钼靶可见钙化的存在,周围DCIS的存在能够更早地检测出3级浸润性癌。检测提示DCIS的钙化应仍然是乳腺钼靶筛查的重要组成部分。

相似文献

1
The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours.乳腺钼靶筛查时原位导管癌的检测有助于诊断小型3级浸润性肿瘤。
Br J Cancer. 1997;75(4):542-4. doi: 10.1038/bjc.1997.94.
2
Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography.既往乳腺钼靶检查中存在的导管原位癌(DCIS)的乳腺钼靶特征。
Clin Radiol. 1999 Oct;54(10):644-6. doi: 10.1016/s0009-9260(99)91083-8.
3
Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.定性放射组学:BI-RADS 钙化描述符与 Oncotype DX 导管原位癌评分评估的复发风险之间的关联。
AJR Am J Roentgenol. 2019 Apr;212(4):919-924. doi: 10.2214/AJR.18.20306. Epub 2019 Feb 4.
4
Mammographic bi-dimensional product: a powerful predictor of successful excision of ductal carcinoma in situ.乳腺钼靶二维乘积:导管原位癌成功切除的有力预测指标。
Clin Radiol. 2007 Aug;62(8):787-91. doi: 10.1016/j.crad.2007.02.015. Epub 2007 May 7.
5
Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project.病灶大小是导管原位癌乳腺 X 线特征的主要决定因素:Sloane 项目的研究结果。
Clin Radiol. 2010 Mar;65(3):181-4. doi: 10.1016/j.crad.2009.05.017. Epub 2010 Jan 18.
6
Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.与无肿块的恶性微钙化病变相关的浸润性癌的存在及大小的乳腺钼靶预测指标。
AJR Am J Roentgenol. 2003 Dec;181(6):1679-84. doi: 10.2214/ajr.181.6.1811679.
7
Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ.乳腺钼靶筛查间隔与导管原位癌大小及组织学之间的关系
AJR Am J Roentgenol. 1999 Feb;172(2):313-7. doi: 10.2214/ajr.172.2.9930774.
8
Mammographic features are associated with clinicopathological characteristics in invasive breast cancer.乳腺 X 线摄影特征与浸润性乳腺癌的临床病理特征相关。
Anticancer Res. 2011 Jun;31(6):2327-34.
9
Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.筛查发现及有症状的导管原位癌:乳腺钼靶特征与病理对照
Radiology. 1994 Apr;191(1):237-40. doi: 10.1148/radiology.191.1.8134579.
10
Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.接受保乳治疗的原位导管癌女性局部复发的乳腺钼靶特征。
AJR Am J Roentgenol. 1997 Feb;168(2):489-93. doi: 10.2214/ajr.168.2.9016233.

引用本文的文献

1
Biomineralogical signatures of breast microcalcifications.乳腺微钙化的生物矿物学特征。
Sci Adv. 2023 Feb 22;9(8):eade3152. doi: 10.1126/sciadv.ade3152.
2
Force-dependent breaching of the basement membrane.力依赖性基底膜突破
Matrix Biol. 2017 Jan;57-58:178-189. doi: 10.1016/j.matbio.2016.12.005. Epub 2016 Dec 23.
3
Microcalcification-Associated Breast Cancer: Presentation, Successful First Excision, Long-Term Recurrence and Survival Rate.微钙化相关乳腺癌:临床表现、首次成功切除、长期复发率及生存率
Breast Care (Basel). 2015 Dec;10(6):380-5. doi: 10.1159/000440794. Epub 2015 Oct 16.
4
Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.导管原位癌的筛查检测及随后发生的浸润性间隔期乳腺癌:一项基于人群的回顾性研究。
Lancet Oncol. 2016 Jan;17(1):109-14. doi: 10.1016/S1470-2045(15)00446-5. Epub 2015 Dec 5.
5
Progression from ductal carcinoma in situ to invasive breast cancer: revisited.从导管原位癌到浸润性乳腺癌的进展:再探讨。
Mol Oncol. 2013 Oct;7(5):859-69. doi: 10.1016/j.molonc.2013.07.005. Epub 2013 Jul 12.
6
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast.缺氧诱导和肿瘤相关碳酸酐酶在乳腺导管原位癌中的表达
Am J Pathol. 2001 Mar;158(3):1011-9. doi: 10.1016/S0002-9440(10)64048-5.

本文引用的文献

1
Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.乳腺非浸润性导管癌:组织学分类的相关性。
Hum Pathol. 1993 Jan;24(1):16-23. doi: 10.1016/0046-8177(93)90057-n.
2
Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.乳腺导管原位癌:乳腺钼靶检查与病理结果的相关性
AJR Am J Roentgenol. 1994 Jun;162(6):1307-11. doi: 10.2214/ajr.162.6.8191988.
3
Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.筛查发现及有症状的导管原位癌:乳腺钼靶特征与病理对照
Radiology. 1994 Apr;191(1):237-40. doi: 10.1148/radiology.191.1.8134579.
4
Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component.对具有导管原位癌成分的浸润性导管癌的评估:原位成分的组织学类型与浸润成分分级的相关性。
Semin Diagn Pathol. 1994 Aug;11(3):215-22.
5
Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.非侵袭性乳腺癌:美国外科医师学会全国调查结果
Ann Surg. 1980 Aug;192(2):139-47. doi: 10.1097/00000658-198008000-00001.
6
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.乳腺钼靶筛查与乳腺癌死亡率:马尔默乳腺钼靶筛查试验
BMJ. 1988 Oct 15;297(6654):943-8. doi: 10.1136/bmj.297.6654.943.
7
Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project.通过乳房筛查检测出的常见和新发癌症的比较病理学。爱丁堡乳房筛查项目。
Lancet. 1986 Mar 8;1(8480):519-23. doi: 10.1016/s0140-6736(86)90882-2.
8
Vexed surgeons, perplexed patients, and breast cancers which may not be cancer.烦恼的外科医生、困惑的患者以及可能并非癌症的乳腺癌。
Cancer. 1990 Feb 1;65(3):387-93. doi: 10.1002/1097-0142(19900201)65:3<387::aid-cncr2820650302>3.0.co;2-y.
9
Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ.乳腺导管原位癌的范围、分布及乳腺钼靶/组织学相关性
Lancet. 1990 Mar 3;335(8688):519-22. doi: 10.1016/0140-6736(90)90747-s.
10
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.乳腺癌的病理预后因素。I. 乳腺癌组织学分级的价值:一项长期随访大型研究的经验
Histopathology. 1991 Nov;19(5):403-10. doi: 10.1111/j.1365-2559.1991.tb00229.x.